AMATO, MARIA PIA

AMATO, MARIA PIA  

Neuroscienze, Psicologia, Area del Farmaco e Salute del Bambino (NEUROFARBA)  

Mostra records
Risultati 1 - 20 di 496 (tempo di esecuzione: 0.027 secondi).
Titolo Data di pubblicazione Autore(i) File
"Brain reserve" and "cognitive reserve" should always be taken into account when studying neurodegeneration - Commentary 2018 Amato, MP;
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. 2009 O'Connor, P; Filippi, M; Arnason, B; Comi, G; Cook, S; Goodin, D; Hartung, Hp; Jeffery, D; Kappos, L; Boateng, F; Filippov, V; Groth, M; Knappertz, V; Kraus, C; Sandbrink, R; Pohl, C; Bogumil, T; Amato, Mp
A 10-year follow-up of the European multicenter trial of interferon β-1b in secondary-progressive multiple sclerosis. 2015 Kuhle, J; Hardmeier, M; Baum, K; Amato, Mp; Buttmann, M
A case of Takotsubo syndrome during a multiple sclerosis brainstem relapse 2018 Prestipino, Elio; Squitieri, Martina; Razzolini, Lorenzo; Pastò, Luisa; Forleo, Paolo; Amato, Maria Pia
A Challenging Diagnosis of Hemophagocytic Lymphohistiocytosis with Unusual Pulmonary Manifestations: A Case Report 2025 Carducci, Claudia; Parronchi, Paola; Portaccio, Emilio; Amato, Maria Pia; Pastó, Luisa; Bartalesi, Filippo; Di Stefano, Gioia; Pasini, Valeria; Comin, Camilla Eva; Ravaglia, Claudia; Poletti, Venerino; Lavorini, Federico; Tomassetti, Sara
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis 2024 Pietro Iaffaldano 1, Giuseppe Lucisano 2, Tommaso Guerra 1, Damiano Paolicelli 1, Emilio Portaccio 3, Matilde Inglese 4 5, Matteo Foschi 6, Francesco Patti 7, Franco Granella 8, Silvia Romano 9, Paola Cavalla 10, Giovanna De Luca 11, Paolo Gallo 12, Paolo Bellantonio 13, Antonio Gallo 14, Sara Montepietra 15, Alessia Di Sapio 16, Marika Vianello 17, Rocco Quatrale 18, Daniele Spitaleri 19, Raffaella Clerici 20, Valentina Torri Clerici 21, Eleonora Cocco 22, Vincenzo Brescia Morra 23, Girolama Alessandra Marfia 24, Vincenzo Daniele Boccia 4, Massimo Filippi 25, Maria Pia Amato , Maria Trojano 1; Italian MS Register
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 2015 Niccolai, Claudia; Portaccio, Emilio; Goretti, Benedetta; Hakiki, Bahia; Giannini, Marta; Pastò, Luisa; Righini, Isabella; Falautano, Monica; Minacapelli, Eleonora; Martinelli, Vittorio; Incerti, Chiara; Nocentini, Ugo; Fenu, Giuseppe; Cocco, Eleonora; Marrosu, Maria Giovanna; Garofalo, Elisa; Ambra, Ferdinando Ivano; Maddestra, Maurizio; Consalvo, Marilena; Viterbo, Rosa Gemma; Trojano, Maria; Losignore, Nunzia Alessandra; Zimatore, Giovanni Bosco; Pietrolongo, Erika; Lugaresi, Alessandra; Pippolo, Lorena; Roscio, Marco; Ghezzi, Angelo; Castellano, Debora; Stecchi, Sergio; Amato, Maria Pia
A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN. 2004 F. Patti; M. P. Amato; M. Filippi; P. Gallo; M. Trojano; G. C. Comi
A first step towards preventive medicine in multiple sclerosis 2023 Amato, Maria Pia; Portaccio, Emilio
A method to compare prospective and historical cohorts to evaluate drug effects. Application to the analysis of early treatment effectiveness of intramuscular interferon-β1a in multiple sclerosis patients 2020 Mallucci G.; Patti F.; Brescia Morra V.; Buccafusca M.; Moiola L.; Amato M.P.; Ferraro E.; Trojano M.; Zaffaroni M.; Mirabella M.; Moscato G.; Plewnia K.; Zipoli V.; Puma E.; Bergamaschi R.
A narrative review of genetic and environmental factors and risk for multiple sclerosis. The design of the Italian multicentric PEDIGREE study 2025 Angelo Ghezzi 1, Sandra D'Alfonso 2, Maura Pugliatti 3, Silvy Pilotto 3, Martina Tosi 2, Andrea Corona 4 5, Alen Zollo 4 5, Nicola Pomella 2, Maria Pia Amato , Eleonora Cocco 8, Maria Trojano 9, Roberto Bergamaschi 10, Filippo Martinelli-Boneschi 4 5; PEDIGREE Study Group
A new paraplegin mutation in a patient with primary progressive multiple sclerosis 2020 Bellinvia A.; Pasto L.; Niccolai C.; Tessa A.; Carrai R.; Martinelli C.; Moretti M.; Amato M.P.; Santorelli F.M.; Sorbi S.; Mata S.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. 2010 Giovannoni G; Comi G; Cook S; Rammohan K; Rieckmann P; Soelberg Sørensen P; Vermersch P; Chang P; Hamlett A; Musch B; Greenberg SJ; MP. Amato; CLARITY Study Group.
A prospective study on the natural history of multiple sclerosis: clues to the conduct and interpretation of clinical trials. 1999 M. P. Amato; G. Ponziani; M. L. Bartolozzi; G. Siracusa
A prospective study on the prognosis of multiple sclerosis. 2000 M. P. Amato; G. Ponziani
A prospective, randomized, controlled trial of autologus haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper. 2012 Saccardi R, Freedman MS; Sormani, Mp; Atkins, H; Fsrge, D; Griffith, Lm; Kraft, G; Gl, Mancardi; Nash, R; Pasquini, M; Martin, R; Amato, Mp
A quality network model for the daily care of multiple sclerosis. 2000 L. D. Blumhardt; B. J. D. Vermeij; M. P. Amato; O. Andersen; G. Edan; O. Fernandez; M. Filippi; J. Haas; O. R. Hommes; P. Rieckmann
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 2009 Portaccio, E;Goretti, B;Zipoli, V;Siracusa, G;Sorbi, S;Amato, MP
A steroid-induced bilateral avascular necrosis of the femoral head in an underage patient affected by multiple sclerosis 2015 Carulli, Christian; Nistri, Lorenzo; Bracco, Laura; Giannini, Marta; Amato, Maria Pia
Abnormal cerebellar functional MRI connectivity in patients with paediatric multiple sclerosis. 2015 Cirillo, S; Rocca, Ma; Ghezzi, A; Valsasina, P; Moiola, L; Veggiotti, P; Amato, Mp; Comi, G; Falini, A; Filippi, M.